Amy M Rocklin Form 3 NEOGEN / Amy M Rocklin ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Rocklin Amy M

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/13/2022

3. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Legal & Reg. Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	10/12/2026	Common Stock	1,176	40.85	D
Restricted Stock Units	(2)	04/25/2027	Common Stock	2,817	28.4	D
Restricted Stock Units	(3)	10/06/2025	Common Stock	27,108	13.28	D
Common Stock (Right to Buy)	(4)	11/12/2026	Common Stock	9,269	40.85	D
Common Stock (Right to Buy)	(5)	05/25/2027	Common Stock	14,724	28.4	D
Common Stock (Right to Buy)	(6)	10/06/2025	Common Stock	120,537	13.28	D

Explanation of Responses:

1. The RSUs were granted on 10/12/2021, have 5 year lives, and vest in equal annual installments on each of the five anniversary dates of the grant

2. The RSUs were granted on 4/25/2022, have five year lives, and vest in equal annual installments on each of the first five anniversary dates of the grant

3. The RSUs were granted on 10/6/2022, have three year lives and vest in equal annual installments on the first three anniversary dates of the grant

4. Options were granted on 10/12/2021,have five year lives and vest in equal annual installments on each of the first five anniversary dates of the grant

5. Options were granted on 4/25/2022, have five year lives, and vest in equal annual installment on each of the first five anniversary dates of the grant

6. Options were granted on 10/6/2022, have three year lives, and vest in equal annual installments on each of the first three anniversary dates of the grant

	Steven J Quinlan (Attorney in Fact)	12/23/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.